Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?
Open Access
- 16 March 2013
- Vol. 68 (7), 691-694
- https://doi.org/10.1136/thoraxjnl-2012-202646
Abstract
Introduction: The rising disease burden from chronic obstructive pulmonary disease (COPD) requires new approaches. Method: We suggest an approach based around three elements: inflammometry and multidimensional assessment to identify therapeutic targets and case management to design and implement an individualised treatment programme based on these assessments. Discussion: This tailored approach to treatment would maximise efficacy, limit cost and permit a better risk–benefit ratio of treatment. The advantages include the ability to add up the benefits of individual therapies leading to a cumulative therapeutic benefit that is greater than each individual therapy alone. We can now design a multifaceted inflammometry intervention for airway diseases based on targeting eosinophilic inflammation, non-eosinophilic pathways and systemic inflammation. COPD is a complex and challenging disease. The use of inflammometry and multidimensional assessment is necessary to identify relevant treatment targets and maximise the scope of therapy while limiting unnecessary use of drugs. An individualised programme of management can be designed and coordinated by using a case manager. This new approach may provide tangible benefits to people with COPDKeywords
This publication has 27 references indexed in Scilit:
- Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trialThe Lancet, 2011
- Azithromycin for Prevention of Exacerbations of COPDThe New England Journal of Medicine, 2011
- Multidimensional assessment of older people with asthma and COPD: clinical management and health statusAge and Ageing, 2010
- Asthma and chronic obstructive pulmonary diseaseCurrent Opinion in Allergy and Clinical Immunology, 2009
- Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsEuropean Respiratory Journal, 2009
- Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertensionClinical Science, 2009
- Usefulness of C-Reactive Protein and Interleukin-6 as Predictors of Outcomes in Patients With Chronic Obstructive Pulmonary Disease Receiving PravastatinThe American Journal of Cardiology, 2008
- International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyThe Lancet, 2007
- Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trialEuropean Respiratory Journal, 2007
- Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary DiseaseJournal of the American College of Cardiology, 2006